Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
For our 8th video in the GRACE Spanish Lung Cancer Library,
Dr. Brian Hunis, Medical Director, Head and Neck Cancer Program, Memorial Cancer Institute, Miami, Florida, joined GRACE to discuss the basics of Lung Cancer for Spanish speaking patients and caregivers, in this video Dr. Hunis reviews the risk factors for lung cancer.
TRANSCRIPTS - Spanish and English
Factores de riesgo del cáncer de pulmón
El riesgo de cancer de pulmón aumenta con el consumo de tabaco. La mayoría de los casos de cancer de pulmón están relacionados al consumo excesivo de tabaco y en pacientes con enfermedad pulmonar crónica.
También existe el riesgo ambiental relacionado al gas radón, que es un gas natural que ocurre en la tierra, además de otras sustancias como el smog y polución ambiental. Por supuesto que existen canceres de pulmón en pacientes que nunca han fumado y también en pacientes que han estado expuestos a tabaco en la familia por exposición a segunda mano También pacientes que han estado expuestos a asbestos, desarrollan asbestosis y con esta tienen un riesgo aumentado de desarrollar cancer de pulmón además de otro tipo de cancer llamado el mesotelioma pleural.
Risk factors for lung cancer
The risk for lung cancer increases with tobacco consumption. Most lung cancer cases are related to excessive use of tobacco and pulmonary chronic disease.
As well, there is an environmental risk that is related with radon gas, which is a natural gas from the earth, and also smog and environmental pollution. There are some lung cancer cases in patients who have never smoked and in patients who have only being secondarily exposed to tobacco with their families. Also, there are patients that have being exposed to asbestos developing asbestosis which increases the risk for lung cancer and of pleural mesothelioma.
Please feel free to offer comments and raise questions in our
discussion forums.
Dr. Singhi's reprise about appropriate treatment, "Right patient, right time, right team".
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...
The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)
There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...
Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.
The...
Biomarkers are genetic mutations (like EGFR, ALK, KRAS, BRAF) or protein levels (like PD-L1) in tumor cells that help guide personalized treatment, especially NSCLC, directing patients to targeted therapies or immunotherapies...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
A Brief Tornado. I love the analogy Dr. Antonoff gave us to describe her presentation. I felt it earlier too and am looking forward to going back for deeper dive.